Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

The Lancet - Tập 365 - Trang 671-679 - 2005
Yixin Wang1, Jan GM Klijn2, Yi Zhang1, Anieta M Sieuwerts2, Maxime P Look2, Fei Yang1, Dmitri Talantov1, Mieke Timmermans2, Marion E Meijer-van Gelder2, Jack Yu1, Tim Jatkoe1, Els MJJ Berns2, David Atkins3, John A Foekens2
1Veridex LLC, a Johnson & Johnson Company, San Diego, CA, USA
2Department of Medical Oncology, Erasmus MC–Daniel den Hoed, Rotterdam, Netherlands
3Veridex LLC, a Johnson & Johnson Company, Warren, NY, USA

Tài liệu tham khảo

Early Breast Cancer Trialists' Collaborative Group, 1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7 Early Breast Cancer Trialists' Collaborative Group, 1998, Tamoxifen for early breast cancer: an overview of randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4 Goldhirsch, 2003, Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer, J Clin Oncol, 21, 3357, 10.1200/JCO.2003.04.576 Eifel, 2001, National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, Nov 1–3, 2000, J Natl Cancer Inst, 93, 979, 10.1093/jnci/93.13.979 Ntzani, 2003, Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment, Lancet, 362, 1439, 10.1016/S0140-6736(03)14686-7 Wang, 2004, Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer, J Clin Oncol, 22, 1564, 10.1200/JCO.2004.08.186 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA, 98, 10869, 10.1073/pnas.191367098 Sørlie, 2003, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci USA, 100, 8418, 10.1073/pnas.0932692100 Gruvberger, 2001, Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns, Cancer Res, 61, 5979 Van't Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a Van de Vijver, 2002, A gene expression signature as a predictor of survival in breast cancer, N Engl J Med, 347, 1999, 10.1056/NEJMoa021967 Ahr, 2002, Identification of high risk breast-cancer patients by gene-expression profiling, Lancet, 359, 131, 10.1016/S0140-6736(02)07337-3 Huang, 2003, Gene expression predictors of breast cancer outcomes, Lancet, 361, 1590, 10.1016/S0140-6736(03)13308-9 Sotiriou, 2003, Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci USA, 100, 10393, 10.1073/pnas.1732912100 Woelfle, 2003, Molecular signature associated with bone marrow micrometastasis in human breast cancer, Cancer Res, 63, 5679 Ma, 2003, Gene expression profiles of human breast cancer progression, Proc Natl Acad Sci USA, 100, 5974, 10.1073/pnas.0931261100 Ramaswamy, 2003, A molecular signature of metastasis in primary solid tumors, Nat Genet, 33, 1, 10.1038/ng1060 Chang, 2003, Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer, Lancet, 362, 362, 10.1016/S0140-6736(03)14023-8 Sotiriou, 2003, Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer, Breast Cancer Res, 4, R3, 10.1186/bcr433 Hedenfalk, 2001, Gene-expression profiles in hereditary breast cancer, N Engl J Med, 344, 539, 10.1056/NEJM200102223440801 Early Breast Cancer Trialists' Collaborative Group, 1995, Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials, N Engl J Med, 333, 1444, 10.1056/NEJM199511303332202 Foekens, 1989, Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer, Cancer Res, 49, 7002 Foekens, 1989, Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols, Cancer Res, 49, 5823 Lipshutz, 1999, High density synthetic oligonucleotide arrays, Nat Genet, 21, 20, 10.1038/4447 Kaplan, 1958, Non-parametric estimation of incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Efron, 1981, Censored data and the bootstrap, J Am Stat Assoc, 76, 312, 10.1080/01621459.1981.10477650 Keyomarsi, 2002, Cyclin E and survival in patients with breast cancer, N Engl J Med, 347, 1566, 10.1056/NEJMoa021153 Herrera-Gayol, 1999, Adhesion proteins in the biology of breast cancer: contribution of CD44, Exp Mol Pathol, 66, 149, 10.1006/exmp.1999.2251 Ransohoff, 2004, Rules of evidence for cancer molecular-marker discovery and validation, Nat Rev Cancer, 4, 309, 10.1038/nrc1322